by clicking the arrows at the side of the page, or by using the toolbar.
by clicking anywhere on the page.
by dragging the page around when zoomed in.
by clicking anywhere on the page when zoomed in.
web sites or send emails by clicking on hyperlinks.
Email this page to a friend
Search this issue
Index - jump to page or section
Archive - view past issues
Australian Journal of Pharmacy : February 2005
BAYER HEALTHCARE JUST GOT HEALTHIER. How would one of the healthcare industry’s most respected companies provide greater services to you? The answer is simple, we join forces with Roche Consumer Health. O n January 1, Bayer Healthcare Consumer Care Division acquired the OTC division of one of our competitors, Roche Consumer Health. It’s a huge investment, but the fit is a natural one. As you know, both our companies have a tradition of creating trusted brands with extensive product development resources. And both companies share a commitment to identifying our customer’s needs. Together, we will be even stronger. By combining under one banner, Bayer Consumer Care has the opportunity to greatly strengthen its market presence. In fact, Bayer Consumer Care can now offer consumers an even bigger portfolio of brands. These include such valued brands as Canesten® Berroca® , Aspirin® Alka-Seltzer® and Rennie® , Aspro® . , Elevit® , Bepanthen® , , The most immediate benefits to you, the customer, will be greater product choice and streamlined ordering. By combining our assets, Bayer Consumer Care’s research and development PORTFOLIO OF BRANDS including Canesten® AN EVEN BIGGER , Berroca® Bepanthen® , Aspirin® , Alka-Seltzer® and Rennie® , Aspro® . , Elevit® , program has become one of the most powerful in our industry. And it’s this product innovation that will drive our future growth. Joining forces with Roche has made Bayer Consumer Care one of the top tier healthcare companies in Australia. With your continued support, we believe Bayer Consumer Care has a great opportunity to become one of the best consumer health and wellness companies in the world. And that’s a healthy position to be in. You should have received the information we have distributed about our new plans. If you have any further questions, contact the following: Pharmacy Orders 1800 008 757 Consumer/Wholesale Enquiries 1800 039 076 or 1800 023 884 Fax 02 9391 6650. BCC0049/AJP